Related Experiment Video
Updated: Jan 15, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Population stratified differences between ATG16L1 rs2241880 polymorphism with Crohn's disease risk: a systematic
Yiyuan Gao1, Yuan Zhang2, Peidu Jiang3
1Department of Pharmacy, Chengdu Eighth People's Hospital, Geriatric Hospital of Chengdu Medical College, Chengdu, China.
Background:
ATG16L1 rs2241880 (T300A), a single-nucleotide variant, plays a controversial role in the development of Crohn's disease (CD).
Aim:
This meta-analysis aimed to explore the association between rs2241880 and CD among different subgroups by collecting the largest sample size published so far.
Methods:
We retrieved articles from China National Knowledge Infrastructure, PubMed, Web of Science, and Embase databases, adhered to the PRISMA 2020 guidelines. The correlation between the rs2241880 variant and CD was assessed with a combined effect size of the calculated 95% confidence interval (CI) and odds ratio (OR). Heterogeneity was assessed by the I2 value among genetic models. Publication bias was tested using the Egger test and funnel plot.
Results:
The rs2241880 G allele is positively correlated with the risk of CD worldwide, with an OR of 1.33 (95% CI: 1.29-1.37) for the comparison of G vs. A. This variant is identified as a risk factor for CD progression across all racial subgroups, particularly highlighting an association between Mongolians and CD risk (G vs. A: OR = 1.24, 95% CI: 1.15-1.34). Furthermore, there are statistically significant differences observed across age subgroups, with adults showing an OR of 1.33 (95% CI: 1.29-1.38) and children an OR of 1.27 (95% CI: 1.10-1.47). Gender-wise, the risk remains significant with a male vs. female comparison yielding an OR of 1.33 (95% CI: 1.29-1.37). Additionally, when comparing the overall co-dominant models, GA carriers exhibited a lower risk compared to GG carriers. Specifically, GA vs. AA showed an OR of 1.30 (95% CI: 1.23-1.38), while GG vs. AA revealed a higher risk with an OR of 1.76 (95% CI: 1.65-1.88).
Conclusion:
The ATG16L1 rs2241880 G allele is associated with an increased risk of CD globally, acting as a risk factor across various demographics, including age (both adults and children), gender, and particularly within Mongolian populations. A gene dosage-dependent effect may enhance the strength of this association, as GG carriers of the ATG16L1 rs2241880 G/A allele polymorphism exhibit a higher risk for CD compared to GA carriers.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
06:21Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF